跳至主要内容
临床试验/DRKS00032780
DRKS00032780招募中Unknown

Implementation of a new treatment scheme for primary hip prosthesis implantations in the German health care system in collaboration with DRV

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift0 个研究点目标入组 70 人开始时间: 2023年10月4日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • •Indication for primary implantation of a total hip joint endoprosthesis
  • •- age: 18 - 80 years
  • •- Patient is gainfully employed

排除标准

  • •- ASA 3-6
  • •- BMI > 34 kg/m2
  • •- Diabetes mellitus with blood glucose imbalances (hypoglycemias)
  • •- Chronic renal failure with GFR < 60 (stage III according to NKF)
  • •- Coronary artery disease with Z.n. intervention within the last 2 years or further complaints
  • •- Permanent anticoagulation with heart valve replacement
  • •- Dementia or other neurological diseases with alteration of gait (Parkinson's syndrome, myasthenia gravis, visual pathway disorders, etc.)
  • •- Anemia / hemophilia / thrombophilia with secondary DVT / LAE
  • •- Known depression / psychoaffective disorder
  • •- Chronic pain patient with long-term opioid medication
  • •- Patients with rheumatoid arthritis with expected limitation in postoperative mobilization
  • •- COPD with limitations in daily life/sleep apnea syndrome
  • •- Lack of compliance for complex treatment procedures
  • •- Language barrier
  • •- Excessive demands in the home situation during outpatient follow-up treatment

研究者

发起方
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift

相似试验